目的 探讨性别决定区Y框蛋白18(sex determining region Y-box 18,SOX18)在前列腺癌中的表达及其对细胞功能的影响.方法 通过免疫组化染色法检测SOX18在98例前列腺癌及其对应的81例正常组织中的表达差异;利用实时荧光定量PCR及蛋白印迹法验证SOX18在前列腺癌细胞系中的表达.利用小干扰RNA对前列腺癌细胞进行转染,通过细胞增殖、迁移及侵袭实验评估SOX18对细胞功能的影响.结果 在98例癌组织中,SOX18高表达阳性率为73.5%(72/98),明显高于癌旁组织(43.2%,35/81) (P <0.01).SOX18高表达的患者在临床分期Ⅲ ~ Ⅳ期、病理分级G3 ~4及Gleason评分≥8分者中所占比例明显高于临床分期Ⅰ~Ⅱ期[83.7%(36/43)与65.5%(36/55),x2=4.131,P=0.042]、病理分级G1 ~2 [88.6%(39/44)与61.7% (33/54),X2=9.424,P=0.002]及Gleason评分≤7分者[85.0%(34/40)与65.0%(38/58),x2=4.610,P=0.032],而不同年龄患者的SOX18高表达比例差异无统计学意义[77.3%(38/54)与70.4%(34/44),x2=0.539,P =0.441].干扰前列腺癌细胞系(PC3和DU145)中SOX18的表达后,细胞的增殖、迁移和侵袭等能力明显降低,差异均有统计学意义(均P<0.05).结论 SOX18在前列腺癌中高表达,且促进前列腺癌细胞的增殖、迁移及侵袭等能力.
Objective To explore the expression of sex determining region Y-box 18 (SOX18) in prostate cancer(PCa) and its role on prostate cancer cells.Methods The expression of SOX18 in 98 PCa tissues and 81 adjacent non-tumor tissues was detected by immunohistochemistry.The expression of SOX18 mRNA and protein in PCa cell lines were detected by q-PCR and Western blotting analysis,respectively.After knocking down SOX18 with si-RNA,the proliferation,migration and invasion of PCa cells were analyzed by CCK8,Transwell and Matrigel assays in vitro.Results The rate of high SOX18 expression in prostate cancer tissues was 73.5% (72/98),which was higher than that in adjacent normal tissues (43.2%,35/81) (P 〈 0.01).In addition,the rates of high SOX18 expression in clinical stage Ⅲ-Ⅳ [83.7 % (36/43) vs.65.5 % (36/55),x2 =4.131,P =0.042],pathological grading G3-4 [88.6% (39/ 44) vs.61.7% (33/54),x2 =9.424,P =0.002] and Gleason scores ≥ 8 [85.0% (34/40) vs.65.0% (38/58),x2 =4.610,P =0.032] groups were higher than those in clinical stage Ⅲ-Ⅳ,pathological grading G1-2 and Gleason scores ≤7 groups.However,there were no differences in the rate of high SOX18 expression in different age groups [77.3% (38/54) vs.70.4% (34/44),x2 =0.539,P =0.441].Knockdown of SOX18 notably suppressed the proliferation,migration and invasion of prostate cancer cells.Conclusions SOX18 is over-expressed in prostate cancer,and could promote the proliferation,migration and invasion ability of prostate cancer cells.